You are subscribed to What's New at CBER for U.S. Food & Drug Administration (FDA).
This page has been updated recently.
November 1, 2013 Blood Products Advisory Committee Meeting Agenda
Posted: 10/29/2013
November 1, 2013 Blood Products Advisory Committee Meeting Public Roster
Posted: 10/29/2013
November 1, 2013 Blood Products Advisory Committee Meeting Issue Summary (PDF - 314KB)
Posted: 10/29/2013
November 1, 2013 Blood Products Advisory Committee Meeting Sponsor Background Package (PDF - 314KB)
Posted: 10/29/2013
October 25, 2013 Approval Letter - Menactra
Posted: 10/29/2013
October 25, 2013 Approval Letter - DAPTACEL
Posted: 10/29/2013
October 25, 2013 Approval Letter - TENIVAC
Posted: 10/29/2013
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
